CONNECT WITH US
Tech

Tech

Claude AI discovers CRISPR-like gene-editing system: All you need to know

Business Standard - Technology logo

Published on

Add as a preferred source on Google
Claude AI discovers CRISPR-like gene-editing system: All you need to know

Home / Technology / Tech News / Claude AI discovers CRISPR-like gene-editing system: All you need to know

Anthropic says 950 Claude agents scanned more than 200,000 reverse transcriptases in 21 hours, identifying a novel system called ART that researchers later validated in a laboratory

The finding is notable because the arrangement of these repeats resembles the architecture of CRISPR (Photo: Freepik)

Vrinda Goel New Delhi 4 min read Last Updated : Sep 25 2026 | 2:38 PM IST

Anthropic has claimed that its flagship artificial intelligence (AI) model Claude has autonomously discovered a novel enzyme system associated with an array of DNA repeats. The finding is notable because the arrangement of these repeats resembles the architecture of CRISPR, the gene-editing technology that has transformed modern medicine and biotechnology.

Anthropic published its findings as a pre-print on September 23. The research has not yet undergone peer review, and the company says the biological function of the newly identified system is still not known.

The system has been named ART, short for array-associated reverse transcriptase. It is found primarily in bacteriophages, viruses that infect bacteria, and consists of three components: a reverse transcriptase (RT), a partner gene located beside it and a long array of evenly spaced DNA repeat sequences.

Reverse transcriptase is an enzyme, or a tiny biological machine, that reads RNA, a molecule carrying genetic instructions, and produces matching DNA. This is the reverse of the process cells usually follow. Some bacteria use reverse transcriptases as part of their basic immune defence against viruses.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.